Literature DB >> 21446328

The effect of hyaluronic acid (Cicatridine) on healing and regeneration of the uterine cervix and vagina and vulvar dystrophy therapy.

J Markowska1, R Madry, A Markowska.   

Abstract

Procedures aimed at the treatment of precancerous lesions and ectopia on the uterine cervix are frequently linked to lesions of anatomical structures. The application of hyaluronic acid (Cicatridine vaginal ovules) promotes accelerated healing of the uterine cervix and acquisition of a normal shape in the uterine cervix canal. Local application of hyaluronic acid in the vagina following radiotherapy due to cancer in the uterine cervix or endometrium favourably affects the healing of post-irradiation lesions in the vagina and improves quality of life. Over 90% of patients responded positively to the application of hyaluronic acid in the form of a cream on dystrophic lesions in the vulva. Hyaluronic acid aids the healing process of post-procedural wounds in the uterine cervix, following radiotherapy applied due to cancer of the uterine cervix, endometrium and in vulvar dystrophy.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21446328

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN： 0392-2936            Impact factor:   0.196


  6 in total

1.  A single-arm clinical trial investigating the effectiveness of a non-hormonal, hyaluronic acid-based vaginal moisturizer in endometrial cancer survivors.

Authors:  Jeanne Carter; Shari Goldfarb; Raymond E Baser; Deborah J Goldfrank; Barbara Seidel; Lisania Milli; Sally Saban; Cara Stabile; Jocelyn Canty; Ginger J Gardner; Elizabeth L Jewell; Yukio Sonoda; Marisa A Kollmeier; Kaled M Alektiar
Journal:  Gynecol Oncol       Date:  2020-06-08       Impact factor: 5.482

2.  Sexual problems during the first 2 years of adjuvant treatment with aromatase inhibitors.

Authors:  Leslie R Schover; George P Baum; Lisa A Fuson; Abenaa Brewster; Amal Melhem-Bertrandt
Journal:  J Sex Med       Date:  2014-08-21       Impact factor: 3.802

3.  Transcription, translation, and function of lubricin, a boundary lubricant, at the ocular surface.

Authors:  Tannin A Schmidt; David A Sullivan; Erich Knop; Stephen M Richards; Nadja Knop; Shaohui Liu; Afsun Sahin; Raheleh Rahimi Darabad; Sheila Morrison; Wendy R Kam; Benjamin D Sullivan
Journal:  JAMA Ophthalmol       Date:  2013-06       Impact factor: 7.389

4.  Acute and late vaginal toxicity after adjuvant high-dose-rate vaginal brachytherapy in patients with intermediate risk endometrial cancer: is local therapy with hyaluronic acid of clinical benefit?

Authors:  Concetta Laliscia; Durim Delishaj; Maria Grazia Fabrini; Alessandra Gonnelli; Riccardo Morganti; Franco Perrone; Roberta Tana; Fabiola Paiar; Angiolo Gadducci
Journal:  J Contemp Brachytherapy       Date:  2016-12-09

5.  A single-arm, prospective trial investigating the effectiveness of a non-hormonal vaginal moisturizer containing hyaluronic acid in postmenopausal cancer survivors.

Authors:  Jeanne Carter; Raymond E Baser; Deborah J Goldfrank; Barbara Seidel; Lisania Milli; Cara Stabile; Jocelyn Canty; Sally Saban; Shari Goldfarb; Maura N Dickler; Ginger J Gardner; Elizabeth L Jewell; Yukio Sonoda; Marisa A Kollmeier; Kaled M Alektiar
Journal:  Support Care Cancer       Date:  2020-05-02       Impact factor: 3.603

Review 6.  Vaginal toxicity after high-dose-rate endovaginal brachytherapy: 20 years of results.

Authors:  Durim Delishaj; Amelia Barcellini; Romerai D'Amico; Stefano Ursino; Francesco Pasqualetti; Ilaria Costanza Fumagalli; Carlo Pietro Soatti
Journal:  J Contemp Brachytherapy       Date:  2018-12-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.